Eric Lazartigues
Eric Lazartigues
Louisiana State University Health Sciences Center New Orleans
Email verificata su - Home page
Citata da
Citata da
Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system
MC Zimmerman, E Lazartigues, RV Sharma, RL Davisson
Circulation research 95 (2), 210-216, 2004
Superoxide mediates the actions of angiotensin II in the central nervous system
MC Zimmerman, E Lazartigues, JA Lang, P Sinnayah, IM Ahmad, ...
Circulation research 91 (11), 1038-1045, 2002
Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system
MF Doobay, LS Talman, TD Obr, X Tian, RL Davisson, E Lazartigues
American Journal of Physiology-Regulatory, Integrative and Comparative …, 2007
ACE2/ANG-(1–7)/Mas pathway in the brain: the axis of good
P Xu, S Sriramula, E Lazartigues
American Journal of Physiology-Regulatory, Integrative and Comparative …, 2011
Angiotensin‐converting enzyme 2 in the brain: properties and future directions
H Xia, E Lazartigues
Journal of neurochemistry 107 (6), 1482-1494, 2008
Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain
MC Zimmerman, RP Dunlay, E Lazartigues, Y Zhang, RV Sharma, ...
Circulation research 95 (5), 532-539, 2004
Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension
Y Feng, H Xia, Y Cai, CM Halabi, LK Becker, RAS Santos, RC Speth, ...
Circulation research 106 (2), 373-382, 2010
The sweeter side of ACE2: physiological evidence for a role in diabetes
SM Bindom, E Lazartigues
Molecular and cellular endocrinology 302 (2), 193-202, 2009
Nicotine and the renin-angiotensin system
JM Oakes, RM Fuchs, JD Gardner, E Lazartigues, X Yue
American Journal of Physiology-Regulatory, Integrative and Comparative …, 2018
Angiotensin I–converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice
SM Bindom, CP Hans, H Xia, AH Boulares, E Lazartigues
Diabetes 59 (10), 2540-2548, 2010
ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension
S Sriramula, JP Cardinale, E Lazartigues, J Francis
Cardiovascular research 92 (3), 401-408, 2011
Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin ii type i receptor–dependent mechanism
MR Deshotels, H Xia, S Sriramula, E Lazartigues, CM Filipeanu
Hypertension 64 (6), 1368-1375, 2014
Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II–mediated pressor and drinking responses and is associated with angiotensin …
Y Feng, X Yue, H Xia, SM Bindom, PJ Hickman, CM Filipeanu, G Wu, ...
Circulation research 102 (6), 729-736, 2008
Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension
H Xia, S Sriramula, KH Chhabra, E Lazartigues
Circulation research 113 (9), 1087-1096, 2013
ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function
H Xia, S Suda, S Bindom, Y Feng, SB Gurley, D Seth, LG Navar, ...
PloS one 6 (7), e22682, 2011
Angiotensin II Type 1 receptor–mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice
H Xia, Y Feng, TD Obr, PJ Hickman, E Lazartigues
Hypertension 53 (2), 210-216, 2009
Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension
J Xu, S Sriramula, H Xia, L Moreno-Walton, F Culicchia, O Domenig, ...
Circulation research 121 (1), 43-55, 2017
Angiotensin-converting enzyme 2: central regulator for cardiovascular function
H Xia, E Lazartigues
Current hypertension reports 12 (3), 170-175, 2010
Brain-Selective Overexpression of Angiotensin (AT1) Receptors Causes Enhanced Cardiovascular Sensitivity in Transgenic Mice
E Lazartigues, SM Dunlay, AK Loihl, P Sinnayah, JA Lang, JJ Espelund, ...
Circulation research 90 (5), 617-624, 2002
Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia
DS Hoffmann, CJ Weydert, E Lazartigues, WJ Kutschke, MF Kienzle, ...
Hypertension 51 (4), 1058-1065, 2008
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20